gaboxadol has been researched along with tiagabine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diemer, NH; Johansen, FF | 1 |
| Steiger, A | 1 |
| Hutson, PH; McDonald, LM; Sheppard, WF; Sohal, B; Staveley, SM; Tattersall, FD | 1 |
| Walsh, JK | 1 |
| Clausen, RP; Ebert, B; Krogsgaard-Larsen, P; Madsen, KK; Schousboe, A; White, HS | 1 |
| Lingford-Hughes, A; Muthukumaraswamy, S; Myers, J; Nutt, D; Papadopoulos, A; Wilson, S | 1 |
2 review(s) available for gaboxadol and tiagabine
| Article | Year |
|---|---|
Neurochemical regulation of sleep.
Topics: Brain; Corticotropin-Releasing Hormone; Electroencephalography; Estrogens; GABA Agonists; GABA-A Receptor Agonists; Growth Hormone-Releasing Hormone; Hormone Replacement Therapy; Humans; Hypnotics and Sedatives; Hypothalamo-Hypophyseal System; Isoxazoles; Neuropeptides; Nipecotic Acids; Pituitary-Adrenal System; Sleep Initiation and Maintenance Disorders; Sleep Stages; Tiagabine | 2007 |
Enhancement of slow wave sleep: implications for insomnia.
Topics: Electroencephalography; GABA Agonists; Humans; Isoxazoles; Nipecotic Acids; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep Stages; Tiagabine | 2009 |
1 trial(s) available for gaboxadol and tiagabine
| Article | Year |
|---|---|
Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: a study in healthy volunteers.
Topics: Adult; Brain; Brain Waves; Cross-Over Studies; Female; GABA Agonists; gamma-Aminobutyric Acid; Humans; Isoxazoles; Magnetoencephalography; Male; Nipecotic Acids; Pyridines; Rest; Single-Blind Method; Synapses; Tiagabine; Young Adult; Zolpidem | 2015 |
3 other study(ies) available for gaboxadol and tiagabine
| Article | Year |
|---|---|
Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells.
Topics: Animals; Arousal; Brain Ischemia; Cell Count; Cell Survival; Diazepam; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Hippocampus; Isoxazoles; Male; Motor Activity; Nerve Degeneration; Neurons; Nipecotic Acids; Rats; Rats, Inbred Strains; Synaptic Transmission; Tiagabine | 1991 |
Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
Topics: Administration, Oral; Amines; Animals; Anticonvulsants; Azabicyclo Compounds; Baclofen; Benzodiazepines; Bicuculline; Brain; Cyclohexanecarboxylic Acids; Discrimination Learning; Dose-Response Relationship, Drug; GABA Agents; GABA Agonists; GABA Antagonists; GABA Plasma Membrane Transport Proteins; Gabapentin; gamma-Aminobutyric Acid; Generalization, Stimulus; Hypnotics and Sedatives; Injections, Intraperitoneal; Isoxazoles; Male; Nipecotic Acids; Piperazines; Pyridines; Rats; Thiophenes; Tiagabine; Zolpidem | 2008 |
Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.
Topics: Animals; Anticonvulsants; Ataxia; Dose-Response Relationship, Drug; Female; GABA Agonists; GABA Plasma Membrane Transport Proteins; Isoxazoles; Male; Mice; Nipecotic Acids; Receptors, GABA-A; Synapses; Tiagabine | 2011 |